医学
变应原免疫治疗
哮喘
免疫疗法
过敏
药物经济学
成本效益
过敏性哮喘
过敏原
狭缝
重症监护医学
免疫学
免疫系统
风险分析(工程)
生物
遗传学
作者
Natalia Rodríguez-Otero,E Ramírez-Mateo,Nieves Plana,Enrico Heffler,Darío Antolín‐Amérigo
标识
DOI:10.1097/aci.0000000000001028
摘要
Allergen immunotherapy is cost-effective in the management of allergic rhinitis and asthma as compared with SOC alone. As most studies consider only during-treatment costs and no long-term benefits or preventive effects are being assessed, the real cost-effectiveness of allergen immunotherapy could be even higher.
科研通智能强力驱动
Strongly Powered by AbleSci AI